Commodity Production Costs Report
Paracetamol Tablets Production
Paracetamol Operating Costs & Plant Construction Costs
This report approaches the conversion of Paracetamol granules into tablets. The economic analysis is based on a plant located in the United States.
The report provides a comprehensive study of Paracetamol production and related Paracetamol production cost, covering three key aspects: a complete description of the Paracetamol production process examined; an in-depth analysis of the related Paracetamol plant capital cost (Capex); and an evaluation of the respective Paracetamol plant operating costs (Opex).
The Paracetamol production process description includes a block flow diagram (BFD), an overview of the industrial site installations, detailing both the process unit and the necessary infrastructure, process consumption figures and comprehensive process flow diagrams (PFD). The Paracetamol plant capital cost analysis breaks down the Capex by plant cost (i.e., ISBL, OSBL and Contingency); owner's cost; working capital; and costs incurred during industrial plant commissioning and start-up. The Paracetamol plant operating costs analysis covers operating expenses, including variable costs like raw materials and utilities, and fixed costs such as maintenance, labor, and depreciation.
Key reference(s): ?
Report in PDF Format
Download & Explore Anytime
Access in Various Devices
Print & Read Comfortably
Share With Co-workers
Up-to-date Report
Professional report based on Q3 2024 economic data, ensuring timely evaluations.
Multiple Use Cases
Ideal for investment screening, feasibility studies, cost estimates, and research planning.
Proven Methodology
Developed using a consistent methodology honed over a decade, ensuring reliable cost analyses.
Report Editions
Content Highlights
Plant Capital Cost Summary
Summary outlining the capital cost required for building the Paracetamol production plant examined.
Plant Capital Cost Details
Detailing of fixed capital (ISBL, OSBL & Owner’s Cost), working capital and additional capital requirements.
Plant Cost Breakdowns
Breakdown of Paracetamol process unit (ISBL) costs and infrastructure (OSBL) costs; plant cost breakdown per discipline.
Operating Costs Summary
Summary presenting the operating variable costs and the total operating cost of the Paracetamol production plant studied.
Operating Cost Details
Detailing of utilities costs, operating fixed costs and depreciation.
Plant Capacity Assessment
Comparative analysis of capital investment and operating costs for different Paracetamol plant capacities.
Production Process Information
Block Flow Diagram, descriptions of process unit (ISBL) and site infrastructure (OSBL).
Process Consumptions
Raw materials and utilities consumption figures, by-products credits, labor requirements
Process Diagrams
Process flow diagrams (PFD), equipment list and industrial site configuration
Preview our Production Cost Reports
Other Paracetamol Production Cost Reports
Paracetamol Production from Nitrobenzene
This report approaches the production of Paracetamol from nitrobenzene and acetic anhydride in the United States. In this process, nitrobenzene is contacted with hydrogen in the presence of dilute sulfuric acid, generating 4-aminophenol (PAP) and aniline by-product. The PAP is then acetylated to produce Paracetamol.
Details: 20 kta United States-based plant | Q3 2024 | 107 pages | Issue B | From $1,999 USD
Paracetamol Production from p-Nitrophenol
This report analyses the economics of Paracetamol production from p-nitrophenol (PNP) and acetic anhydride. The PNP is then subjected to reduction, producing p-aminophenol (PAP). The PAP is then acetylated to produce Paracetamol. The economic analysis is based on a plant located in the United States.
Details: 20 kta United States-based plant | Q3 2024 | 107 pages | Issue D | From $1,999 USD
Paracetamol Production from p-Nitrochlorobenzene
This report analyses the economics of Paracetamol production from 4-nitrochlorobenzene and acetic anhydride in the United States. In the process, 4-nitrochlorobenzene reacts with sodium hydroxide producing para nitro phenol (PNP). The PNP is then subjected to reduction, producing para amino phenol (PAP). The PAP is then acetylated to produce Paracetamol.
Details: 20 kta United States-based plant | Q3 2024 | 107 pages | Issue A | From $1,999 USD
Could Not Find the Report You Need?
Obtain a Bespoke Report
Get a report targeting the process in which you are interested
See Offer Details
Understand Bespoke Reports and how you can easily order them
Check Editions & Pricing
Complete a brief form and see a quotation for your Bespoke Report
Other Related Production Cost Reports
Rifampicin Production
This report presents the economics of Rifampicin production from mixed carbon sources (peanut meal, soybean flour, glucose, and starch) in the United States, via a typical fermentation process of Nocardi mediterranei. The fermentation produces rifamycin B, which is further processed in many steps until Rifampicin is obtained.
Details: 0.1 kta United States-based plant | Q3 2024 | 107 pages | Issue A | From $1,999 USD
Amoxicillin Production
This report presents the economics of Amoxicillin Trihydrate production from D(-)p-hydroxyphenylglycine and 6-APA in the United States. The process examined is a conventional chemical synthesis (via the Dane salt route).
Details: 0.4 kta United States-based plant | Q3 2024 | 107 pages | Issue A | From $1,999 USD
Cefalotin Production
This report presents the economics of a typical Cefalotin production process in the United States. In this process, 2-TAC is reacted in 7-ACA suspension, with sodium acetate added to the reaction mixture for crystallization.
Details: 0.1 kta United States-based plant | Q3 2024 | 107 pages | Issue A | From $1,999 USD
Pyrantel Pamoate Production
This report presents the economics of Pyrantel Pamoate production from 2-thiophene aldehyde in the United States. 3-Methylamine propylamine is first sent to a cyclization step before it is reacted with 2-thiophene aldehyde. Ethanol and citric acid are added to the reaction product, followed by the addition of a pamoic acid solution for recrystallization, obtaining pyrantel pamoate.
Details: 0.1 kta United States-based plant | Q3 2024 | 107 pages | Issue A | From $1,999 USD
+800 Reports Developed, Targeting +250 Commodities
Vast Report Library
858 independent and up-to-date reports examining embryonic and established production processes.
Free Sample Reports
Quickly understand the structure and depth of content of our professional reports.